Target Price | $3.99 |
Price | $1.41 |
Potential |
183.10%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target OPKO Health, Inc. 2026 .
The average OPKO Health, Inc. target price is $3.99.
This is
183.10%
register free of charge
$8.50
502.84%
register free of charge
$2.00
41.84%
register free of charge
|
|
A rating was issued by 7 analysts: 6 Analysts recommend OPKO Health, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the OPKO Health, Inc. stock has an average upside potential 2026 of
183.10%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 713.14 | 667.59 |
17.41% | 6.39% | |
EBITDA Margin | -24.59% | -14.88% |
302.50% | 39.49% | |
Net Margin | -7.53% | -18.11% |
61.25% | 140.39% |
7 Analysts have issued a sales forecast OPKO Health, Inc. 2025 . The average OPKO Health, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an OPKO Health, Inc. EBITDA forecast 2025. The average OPKO Health, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 OPKO Health, Inc. Analysts have issued a net profit forecast 2025. The average OPKO Health, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.08 | -0.18 |
68.00% | 125.00% | |
P/E | negative | |
EV/Sales | 1.53 |
2 Analysts have issued a OPKO Health, Inc. forecast for earnings per share. The average OPKO Health, Inc. EPS is
This results in the following potential growth metrics and future valuations:
OPKO Health, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Locked
➜
Locked
|
Locked | Apr 25 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
Barrington Research |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
Barrington Research |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
Analyst Rating | Date |
---|---|
Locked
JP Morgan:
Locked
➜
Locked
|
Apr 25 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 07 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 19 2025 |
Locked
Barrington Research:
Locked
➜
Locked
|
Mar 12 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 12 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 03 2025 |
Locked
Barrington Research:
Locked
➜
Locked
|
Feb 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.